Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan;115(1):18-40.
doi: 10.14309/ajg.0000000000000486.

ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation

Douglas A Simonetto  1 , Ashwani K Singal  2 , Guadalupe Garcia-Tsao  3 , Stephen H Caldwell  4 , Joseph Ahn  5 , Patrick S Kamath  1
Affiliations
Review

ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation

Douglas A Simonetto et al. Am J Gastroenterol. 2020 Jan.

Abstract

Disorders of the mesenteric, portal, and hepatic veins and mesenteric and hepatic arteries have important clinical consequences and may lead to acute liver failure, chronic liver disease, noncirrhotic portal hypertension, cirrhosis, and hepatocellular carcinoma. Although literature in the field of vascular liver disorders is scant, these disorders are common in clinical practice, and general practitioners, gastroenterologists, and hepatologists may benefit from expert guidance and recommendations for management of these conditions. These guidelines represent the official practice recommendations of the American College of Gastroenterology. Key concept statements based on author expert opinion and review of literature and specific recommendations based on PICO/GRADE analysis have been developed to aid in the management of vascular liver disorders. These recommendations and guidelines should be tailored to individual patients and circumstances in routine clinical practice.

PubMed Disclaimer

Comment in

  • Controversies in Budd-Chiari Syndrome Management: Potential Role of Liver Stiffness.
    Mancuso A, Amata M, Politi F, Mitra M, Marsala MGL, Maringhini A. Mancuso A, et al. Am J Gastroenterol. 2020 Jun;115(6):952-953. doi: 10.14309/ajg.0000000000000586. Am J Gastroenterol. 2020. PMID: 32287138 No abstract available.
  • Response to Mancuso et al.
    Simonetto DA, Singal AK, Garcia-Tsao G, Caldwell SH, Ahn J, Kamath PS. Simonetto DA, et al. Am J Gastroenterol. 2020 Jun;115(6):953. doi: 10.14309/ajg.0000000000000687. Am J Gastroenterol. 2020. PMID: 32427682 No abstract available.

References

    1. Intagliata NM, Argo CK, Stine JG, et al. Concepts and controversies in haemostasis and thrombosis associated with liver disease: Proceedings of the 7th International Coagulation in Liver Disease Conference. Thromb Haemost 2018;118:1491–506.
    1. Hedner U. Recombinant activated factor VII: 30 years of research and innovation. Blood Rev 2015;29(Suppl 1):S4–8.
    1. Tripodi A, Primignani M, Lemma L, et al. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis. J Hepatol 2013;59:265–70.
    1. Leebeek FW, Kluft C, Knot EA, et al. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis. Gastroenterology 1991;101:1382–90.
    1. Tripodi A, Primignani M, Chantarangkul V, et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 2009;137:2105–11.